Replies to post #500613 on NorthWest Biotherapeutics Inc (NWBO)

[newman2021]

BSB, Merck is thinking. To go buy a company that perfects tweaking the chemos with their antibody-drug-conjugates where there is little improvement or go buy a immunotherapy vaccine company where there is a cure which can extend the life of the Keytruda kingdom for sure. Merck is thinking, the proof is it is still NOT buying SGEN. LP told Merck no pennies on the dollars, come with the bank, hahahaha.

[ATLnsider]

Thanks for sharing, Basin Street Blues.

[Know-Fear]

Interesting. As an MRK shareholder I’ve previously stated I expect them to exhaust non-autologous therapies before moving to/on autologous therapies. Certainly gives an idea what MRK is willing to pay for a revenue generating entity with some proprietary art in manufacturing.